Myeloproliferative neoplasms (MPNs) include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Patients with MPNs are prone to develop arterial and venous thrombosis either at diagnosis or during follow-up; in particular splancnic vein is strongly associated with MPN. Conversely, presence of MPN is uncommon in patients with deep vein thrombosis of the lower extremities and with pulmonary embolism. Only few studies with conflicting results have evaluated the prevalence of an underlying MPN in patients with cerebral venous thrombosis (CVT), and limited evidence exists on the incidence of CVT in patients with established MPN.
Dentali, F., Ageno, W., Rumi, E., Casetti, I., Poli, D., Scoditti, U., Maffioli, M., Di Minno, M., Caramazza, D., Pietra, D., De Stefano, V., Passamonti, F., Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases, <<THROMBOSIS RESEARCH>>, 2014; 134 (1): 41-43. [doi:10.1016/j.thromres.2014.03.040] [http://hdl.handle.net/10807/64560]
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases
De Stefano, Valerio;
2014
Abstract
Myeloproliferative neoplasms (MPNs) include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Patients with MPNs are prone to develop arterial and venous thrombosis either at diagnosis or during follow-up; in particular splancnic vein is strongly associated with MPN. Conversely, presence of MPN is uncommon in patients with deep vein thrombosis of the lower extremities and with pulmonary embolism. Only few studies with conflicting results have evaluated the prevalence of an underlying MPN in patients with cerebral venous thrombosis (CVT), and limited evidence exists on the incidence of CVT in patients with established MPN.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
